The Galien Foundation Announces 2015 Prix Galien USA
`Nominees for "Best Biotechnology Product," "Best Pharmaceutical
`Agent," and "Best Medical Technology"
`Winners to be Recognized by Research and Academic Leaders on October 27th at the 2015 Prix Galien USA Awards Ceremony in
`New York City
`Aug 06, 2015, 11:00 ET from Galien Foundation
`
`Galien Foundation (cid:197)(cid:197)(cid:197)
` Facebook
` Twitter
`
`
`
` Pinterest
`
`NEW YORK, Aug. 6, 2015 /PRNewswire/ -- The Galien Foundation today announced the 2015 nominees for the ninth annual Prix Galien USA
`Awards. The Prix Galien Award is considered the biomedical industry's highest accolade and recognizes the technical, scienti(cid:126)c and clinical
`research skills necessary to develop innovative medicines and devices.
`
`Nominees include biomedical products across three categories – biotechnology, pharmaceutical, and technology products – that advance the
`human condition and which were approved by the U.S. Food and Drug Administration (FDA) during the past (cid:126)ve years.
`
`Nominees for the Prix Galien USA 2015 Awards are:
`
`

`

`Amgen
`Bristol-Myers Squibb
`Eli Lilly and Company
`Eli Lilly and Company
`Genentech
`GSK
`Merck & Co., Inc.
`Pfizer Inc.
`Takeda
`
`Best Biotechnology Product (Nominees)
`®
`BLINCYTO (blinatumomab)
`®
`OPDIVO (nivolumab)
`®
`CYRAMZA (ramucirumab)
`™
`TRULICITY (dulaglutide)
`®
`KADCYLA (ado-trastuzumab emtansine)
`®
`BENLYSTA (belimumab)
`KEYTRUDA (pembrolizumab)
`TRUMENBA (Meningococcal Group B Vaccine)
`®
`ENTYVIO (vedolizumab)
`
`® ®
`
`Acorda Therapeutics, Inc.
`Actavis
`Actelion Pharmaceuticals, Ltd.
`Arena Pharmaceuticals, Inc. & Eisai, Inc.
`Astellas Pharma Inc. & Medivation
`AstraZeneca
`Bayer HealthCare Pharmaceuticals
`Biogen
`Bristol-Myers Squibb & Pfizer, Inc.
`Celgene Corporation
`Celgene Corporation
`Eisai Inc.
`Genentech
`Gilead Sciences, Inc.
`GSK/ Novartis Pharmaceuticals Corporation
`Helsinn Group
`Janssen Biotech, Inc. & Pharmacyclics LLC, an AbbVie Company
`Merck & Co., Inc.
`Merck & Co., Inc.
`Merck & Co., Inc.
`Novartis Pharmaceuticals Corporation
`Pfizer, Inc.
`The Medicines Company
`Valeant Pharmaceuticals International, Inc.
`
`Best Pharmaceutical Agent (Nominees)
`®
`AMPYRA (dalfampridine)
`®
`DALVANCE (dalbavancin)
`®
`OPSUMIT (macitentan)
`BELVIQ (lorcaserin HCl) CIV
`XTANDI (enzalutamide)
`™
`LYNPARZA (olaparib)
`®
`ADEMPAS (riociguat)
`®
`TECFIDERA (dimethyl fumarate)
`ELIQUIS (apixaban)
`OTEZLA (apremilast)
`®
`POMALYST (pomalidomide)
`®
`HALAVEN (eribulin mesylate)
`ESBRIET (pirfenidone)
`HARVONI (ledipasvir/sofosbuvir)
`®
`MEKINIST (trametinib)/TAFINLAR (dabrafenib)
`®
`AKYNZEO (netupitant/palonosetron)
`IMBRUVICA (ibrutinib)
`BELSOMRA (suvorexant) C-IV
`™
`ZERBAXA (ceftolozane/tazobactam)
`®
`ZONTIVITY (vorapaxar)
`ZYKADIA (ceritinib)
`XELJANZ (tofacitinib citrate)
`®
`ORBACTIV (oritavancin)
`®
`JUBLIA (efinaconazole)
`
`® ® ™
`
`® ®
`
`® ®
`
`® ®
`
`™ ®
`
`Best Medical Technology (Nominees)
`®
`VITEK MS
`™
`The ALAIR Bronchial Thermoplasty System
`™
`PRECISION SPECTRA Spinal Cord
`Stimulator System
`™
`SAPIEN 3 Transcatheter Heart Valve
`®
`COLOGUARD
`®
`™
`THERMOCOOL SMARTTOUCH Catheter
`& Software Module
`®
`ATTUNE Knee System
`®
`EVARREST Fibrin Sealant Patch
`®
`MOBI-C Cervical Disc
`®
`®
`COFLEX Interlaminar Stabilization
`T2Candida Panel
`™
`FlowFusion ND Infusion Catheter
`
`bioMerieux
`Boston Scientific
`Boston Scientific
`
`Edwards Lifesciences
`Exact Sciences Corporation
`
`Johnson & Johnson (Biosense Webster)
`Johnson & Johnson (DePuy Synthes Companies)
`Johnson & Johnson (Ethicon)
`LDR
`Paradigm Spine
`T2 Biosystems, Inc.
`Cook Regentec
`
`"Biomedical research can only exist when there are those who are willing to push innovation and apply new understanding to the discovery of
`new drugs and technology," remarked Dr. P. Roy Vagelos, Chairman of the Awards Committee.(cid:197)"This year's nominees(cid:197)are catalysts for the
`development of disease-altering advances that bring new hope to patients through biopharmaceutical and medical technology innovation. It is
`upon these values that the Galien Foundation is predicated, and we're proud to honor those in the (cid:126)eld who exemplify these same principles."
`
`The Prix Galien USA Committee, comprised of 10 renowned leaders from the biomedical industry and academia, including (cid:126)ve Nobel Laureates,
`is responsible for evaluating nominees. Winners will be honored at the Prix Galien USA Awards Ceremony on October 27, 2015 at 6:30 p.m., at the
`American Museum of Natural History in New York City.(cid:197)Registration for the 2015 Prix Galien USA Awards Ceremony is open and can be accessed
`here.
`
`Galien Awards Committee 2015
`
`

`

`Pr Richard Axel, M.D., Nobel Laureate, Co-director, the Kavli Institute for Brain Science, Columbia University Medical Center, New York.
`Pr Michael S. Brown, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center at
`Dallas.
`Pr Laurie Glimcher, M.D., Dean of Weill Cornell Medical College and Provost for Medical Affairs, Cornell University, New York.
`Pr Joseph Goldstein, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center at
`Dallas.
`Pr Robert S. Langer, M.D., David H. Koch Institute Professor at MIT.
`Pr Paul A. Marks, M.D., Laboratory Head (cid:197)of Cell Biology Memorial Sloan-Kettering Cancer Center, New York . President, Emeritus, MSKCC.
`Pr Bengt Samuelsson, M.D., Ph.D., Nobel Laureate, Former President of Karolinska Institute and Former Chairman of the Nobel Foundation.
`Pr Marc Tessier-Lavigne, Ph.D., President and Professor Laboratory of Brain Development and Repair, The Rockefeller University, New York.
`Pr Roy Vagelos, M.D., Chairman. Chairman of Regeneron Pharmaceuticals and Retired Chairman and Chief Executive Of(cid:126)cer of Merck & Co.,
`Inc.
`Pr Elie Wiesel, Peace Nobel Laureate, Boston University Professor Emeritus. Honorary Member.
`
`About the Galien Foundation
`The Galien Foundation fosters, recognizes and rewards excellence in scienti(cid:126)c innovation to improve the state of human health. Our vision is to
`be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save
`lives.
`
`The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements
`in improving the human condition through the development of innovative therapies. The Prix Galien was created in France in 1970 in honor of
`Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in
`biopharmaceutical and medical technology research.
`
`For more information visit www.galienfoundation.org.
`
`Galien Foundation Media Contact:
`Lee Davies
`Makovsky on behalf of The Galien Foundation
`ldavies@makovsky.com
`212-508-9651
`
`Logo - http://photos.prnewswire.com/prnh/20150806/256321LOGO
`
`SOURCE Galien Foundation
`
`RELATED LINKS
`http://galienfoundation.org
`
`